Contact
searchSearch
HMP Global
Videos

An Introduction to the Aperta NSE PTA Balloon Technology: A New Tool for Treating Peripheral Arterial Disease

Craig M. Walker, MD, FACC, FACP, FSCAI, FCCP
01/14/2025

 

International thought leader Craig Walker, MD, discusses the new scoring technology Aperta NSE PTA, describing its features and the potential benefits based upon his early use and the unique features of the technology.

Stay in the Know

Vascular Disease Management Newsletter

News

Venous Leg Ulcers
Spectrum Venous Leg Ulcer Study Demonstrates Clinical Support for Use of VenaSeal™ in Advanced Superficial Venous Disease
04/24/2025
Results from study indicate strong healing rate of chronic venous ulcers when VenaSeal™ is used in patients with advanced superficial venous disease Medtronic, the global leader in health care technology, today announced the primary and...
Results from study indicate strong healing rate of chronic venous ulcers when VenaSeal™ is used in patients with advanced superficial venous disease Medtronic, the global leader in health care technology, today announced the primary and...
Results from study indicate...
04/24/2025
Vascular Disease Management
Peripheral Arterial Disease
Efemoral Medical Releases Positive Long-Term Results from EFEMORAL I
04/23/2025
EFEMORAL I is a first-in-human clinical trial evaluating the performance of the Efemoral Vascular Scaffold System (EVSS) for the treatment of patients suffering symptomatic peripheral arterial occlusive disease from atherosclerosis of the...
EFEMORAL I is a first-in-human clinical trial evaluating the performance of the Efemoral Vascular Scaffold System (EVSS) for the treatment of patients suffering symptomatic peripheral arterial occlusive disease from atherosclerosis of the...
EFEMORAL I is a first-in-human...
04/23/2025
Cath Lab Digest
News
HMP Global’s Amputation Prevention Symposium (AMP) at 15: Fresh Faces Shaping the Future of Limb Preservation
04/22/2025
MALVERN Pa., (April 22, 2025) — Insights and innovations in limb preservation are the focus of HMP Global’s 15th annual Amputation Prevention Symposium (AMP). With the theme of “Where the Field Moves Ahead,” AMP this year introduces Lead...
MALVERN Pa., (April 22, 2025) — Insights and innovations in limb preservation are the focus of HMP Global’s 15th annual Amputation Prevention Symposium (AMP). With the theme of “Where the Field Moves Ahead,” AMP this year introduces Lead...
MALVERN Pa., (April 22, 2025) —...
04/22/2025
Vascular Disease Management
Amputation Prevention Symposium
HMP Global’s Amputation Prevention Symposium (AMP) at 15
04/22/2025
2025 meeting led by Dr. Richard Neville and Dr. Bret Wiechmann; new Course Directors include Dr. Kumar Madassery, Dr. John Phillips, and Dr. Ahmed Kayssi MALVERN Pa., (April 22, 2025) — Insights and innovations in limb preservation are the...
2025 meeting led by Dr. Richard Neville and Dr. Bret Wiechmann; new Course Directors include Dr. Kumar Madassery, Dr. John Phillips, and Dr. Ahmed Kayssi MALVERN Pa., (April 22, 2025) — Insights and innovations in limb preservation are the...
2025 meeting led by Dr. Richard...
04/22/2025
Vascular Disease Management
Lower-extremity intervention
First Patient Treated in ELITE-BTK Pivotal Trial for Below-the-Knee PAD Using R3 Vascular's Magnitude Drug-Eluting Bioresorbable Scaffold
04/22/2025
The first patient in its ELITE-BTK pivotal trial was treated by Dr. Brian DeRubertis, FACS, Chief of the Division of Vascular & Endovascular Surgery at NewYork-Presbyterian and Weill Cornell Medicine in New York City.
The first patient in its ELITE-BTK pivotal trial was treated by Dr. Brian DeRubertis, FACS, Chief of the Division of Vascular & Endovascular Surgery at NewYork-Presbyterian and Weill Cornell Medicine in New York City.
The first patient in its...
04/22/2025
Cath Lab Digest
BTK Intravascular IMaging
Cagent Vascular Initiates Patient Enrollment in the Serranator vs. POBA OCT Study at Columbia University Medical Center
04/17/2025
This prospective, randomized (2:1 treatment to control) dual-center study will enroll up to 60 subjects. The study will utilize intravascular optical coherence tomography (OCT) imaging to demonstrate the mechanism of action (MOA) of the...
This prospective, randomized (2:1 treatment to control) dual-center study will enroll up to 60 subjects. The study will utilize intravascular optical coherence tomography (OCT) imaging to demonstrate the mechanism of action (MOA) of the...
This prospective, randomized...
04/17/2025
Cath Lab Digest
ischemic stroke
ANAIS Study Results Support Use of Anaconda Biomed's ANA Funnel Catheter as Adjunct to Stent Retriever Thrombectomy in Treatment of Acute Ischemic Stroke
04/17/2025
The data demonstrated high rates of reperfusion and first-pass success with a strong safety profile, supporting the ANA device as an adjunct to stent retriever thrombectomy in the treatment of acute ischemic stroke.
The data demonstrated high rates of reperfusion and first-pass success with a strong safety profile, supporting the ANA device as an adjunct to stent retriever thrombectomy in the treatment of acute ischemic stroke.
The data demonstrated high rates...
04/17/2025
Cath Lab Digest
Vascular Disease Awareness
Primary Care Providers Identify a Major Health Crisis for Seniors -- One Most Have Never Heard Of
04/15/2025
Society for Vascular Surgery urges primary care providers to work with vascular surgeons to enhance patient outcomes and quality of life ROSEMONT, Ill., April 15, 2025 /PRNewswire/ -- According to a new national survey released by the...
Society for Vascular Surgery urges primary care providers to work with vascular surgeons to enhance patient outcomes and quality of life ROSEMONT, Ill., April 15, 2025 /PRNewswire/ -- According to a new national survey released by the...
Society for Vascular Surgery...
04/15/2025
Vascular Disease Management
thrombectomy
Seven New Data Sets Demonstrate Penumbra’s Computer Assisted Vacuum Thrombectomy (CAVT) Technology Is Safe, Fast and Effective, Improves Patient Outcomes, and Delivers Healthcare Resource Benefits
04/07/2025
Penumbra, Inc, announced seven significant computer assisted vacuum thrombectomy (CAVT™) data presentations during the 2025 Society of Interventional Radiology (SIR) Annual Scientific Meeting. The data showed that CAVT as a frontline therapy...
Penumbra, Inc, announced seven significant computer assisted vacuum thrombectomy (CAVT™) data presentations during the 2025 Society of Interventional Radiology (SIR) Annual Scientific Meeting. The data showed that CAVT as a frontline therapy...
Penumbra, Inc, announced seven...
04/07/2025
Cath Lab Digest
Aortic Lesions
Gore Announces FDA Approval and First Commercial Implant of Large-Diameter Thoracic Tapers
04/03/2025
FLAGSTAFF, Ariz. (March 24, 2025) — W. L. Gore & Associates (Gore) today announced the expansion of the GORE® TAG® Conformable Thoracic Stent Graft with ACTIVE CONTROL System product line, following FDA approval of four new large-diameter...
FLAGSTAFF, Ariz. (March 24, 2025) — W. L. Gore & Associates (Gore) today announced the expansion of the GORE® TAG® Conformable Thoracic Stent Graft with ACTIVE CONTROL System product line, following FDA approval of four new large-diameter...
FLAGSTAFF, Ariz. (March 24,...
04/03/2025
Vascular Disease Management

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use